Table 3: Basic angiographic data and echo findings, treatment provided and interventional data.

Characteristics Patients (n = 280) Male (n = 140) Female (n = 140)
ECHO
   Normal 176 (62.9%) 81 (57.9%) 95(67.9%)3
   Mild dysfunction 60 (21.4%) 35 (25%) 25 (17.9%)
   Moderate dysfunction 38 (13.6%) 20 (14.3%) 18 (12.9%)
   Severe dysfunction 6 (2.2%) 4 (2.8%) 2 (1.4%)
   Ejection fraction less than 25% 6 (2.1%) 4 (2.9%) 2 (1.4%)
   Mitral regurgitation more than class 3 12 (4.3%) 0 12 (8.6%)
Coronary angiographic findings
   TVD 46 (16.4%) 20 (14.3%) 26 (18.6%)
   DVD 49 (17.5%) 33 (23.6%) 16 (11.4%)
   SVD 67 (23.9%) 34 (24.3%) 33 (23.6%)
   LMD 5 (1.8%) 1 (0.7%) 4 (2.9%)
   LMD + DVD 6 (2.1%) 6 (4.3%) 0
   LMD + TVD 8 (2.9%) 4 (2.9%) 4 (2.9%)
   Mild CAD 42 (15%) 16 (11.4%) 26 (18.6%)
   Normal 57 (20.4%) 26 (18.6%) 31 (22.1%)
Treatment selected
   PCI 116 (41.4%) 69 (49.3%) 47 (33.6%)
   CABG 43 (15.4%) 18 (12.9%) 25 (17.9%)
   Medical 121 (43.2%) 53 (37.9%) 68 (48.6%)
   PCPCI angiographic data
   Bare metal stent (BMS) 18 (15.5%) 8 (11.6%) 10 (21.3%)
   Drug eluting stent (DES) 97 (84.5%) 61 (88.4%) 36 (78.7%)
   Failure of PCI 1 (0.9%) 0 1 (2.1%)
   Bifurcation stenting 5 (4.3%) 1 (1.4%) 4 (8.5%)
   PCI of ISR 4 (3.4%) 2 (2.9%) 2 (4.3%)

TVD: Triple Vessel Disease; DVD: Double Vessel Disease; SVD: Single Vessel Disease; LM: Left Main; CAD: Coronary Artery Disease; MR: Mitral Regurgitation; EF: Ejection Fraction; PCI: Percutaneous Coronary Intervention; CABG: Coronary Artery Bypass Grafting; BMS: Bare Metal Stent; DES: Drug Eluting Stent; ISR: Instent Restenosis